← American Chemistry Council
EPARulemakingEPA-HQ-OPPT-2020-0744

n-Methylpyrrolidone (NMP); Rulemaking under TSCA Section 6(a)(CASRN 872-50-4)

RIN
—
Last modified
Sep 11, 2024
Comment window
closed 729d ago
American Chemistry Council filings
2

Activity

American Chemistry Council filed 2 comments on this docket between Aug 1, 2024 and Aug 1, 2024. 25 other organizations filed here. The comment window closed 729d ago.

What American Chemistry Council filed (2)

Aug 1, 2024· Comment submitted by American Chemistry Council (ACC)· EPA-HQ-OPPT-2020-0744-0323

Additional attachment to ACC July 29, 2024 comments on NMP Proposed Rule: previously filed comments on NMP revised risk determination

View on regulations.gov →
Aug 1, 2024· Comment submitted by American Chemistry Council (ACC)· EPA-HQ-OPPT-2020-0744-0321

Comments of the American Chemistry Council on EPA's Proposed Risk Management Rule for NMP under TSCA are attached, along with its attachment, ACC's Dermal Monitoring Decision Framework.

View on regulations.gov →

Abstract

Section 6 of the Toxic Substances Control Act (TSCA) requires EPA to address unreasonable risks that the Administrator has determined are presented by a chemical substance under the conditions of use. Following a risk evaluation carried out under the authority of TSCA section 6, EPA has determined that n-methylpyrrolidone (NMP) (CASRN 872-50-4) presents unreasonable risks of injury to health. EPA is initiating rulemaking under TSCA section 6 to address these unreasonable risks.

View on regulations.gov →

Co-filers (25)

See everyone who commented →
n-Methylpyrrolidone (NMP); Rulemaking under TSCA Section 6(a)(CASRN 872-50-4) (EPA) — American Chemistry Council | OpenPolis